Predictive Autoimmune Biomarkers LLC

Predictive Autoimmune Biomarkers LLC

Welcome to Predictive Autoimmune Biomarkers LLC

About Us


image-placeholder

Biomarkers to Shorten Clinical Trials

  • Our biomarker  PAB-ENDOINSULINδ1pδ2   has been clinically validated as an early endpoint for insulin preservation studies in Type 1 Diabetes, cutting clinical trial length in half.

image-placeholder

Biomarkers for Individualized Treatment of Automimmune Diseases

PAB-ENDOINSULINδ1pδ2 can be used in clinic to rule out ineffective immunotherapies for Type 1 Diabetes early in the treatment process.

image-placeholder

Exclusive Licensing Available

Our customer is the medical testing industry and we offer an exclusive licensing agreement for  PAB-ENDOINSULINδ1pδ2 .

Subscribe

Contact Us


Drop us a line!

Predictive Autoimmune Biomarkers LLC

41559 Cardinal St., Mattawan, MI 49071, US

(312) 520-5560